Cargando…
Preserving and restoring bone with continuous insulin infusion therapy in a mouse model of type 1 diabetes
Those with type 1 diabetes (T1D) are more likely to suffer a fracture than age- and sex-matched individuals without diabetes, despite daily insulin therapy. In rodent studies examining the effect of bone- or glucose-targeting therapies on preventing the T1D-related decrease in bone strength, insulin...
Autores principales: | Nyman, Jeffry S., Kalaitzoglou, Evangelia, Clay Bunn, R., Uppuganti, Sasidhar, Thrailkill, Kathryn M., Fowlkes, John L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508511/ https://www.ncbi.nlm.nih.gov/pubmed/28736738 http://dx.doi.org/10.1016/j.bonr.2017.07.001 |
Ejemplares similares
-
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
por: Bunn, R Clay, et al.
Publicado: (2023) -
Postnatal loss of the insulin receptor in osteoprogenitor cells does not impart a metabolic phenotype
por: Fowlkes, John L., et al.
Publicado: (2020) -
Emerging therapies for the treatment of rare pediatric bone disorders
por: Thrailkill, Kathryn M., et al.
Publicado: (2022) -
Loss of Insulin Receptor in Osteoprogenitor Cells Impairs Structural Strength of Bone
por: Thrailkill, Kathryn, et al.
Publicado: (2014) -
Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice
por: Fowlkes, John L., et al.
Publicado: (2015)